Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125998524 | 12599852 | 4 | F | 201606 | 20160907 | 20160727 | 20160913 | EXP | US-PFIZER INC-2016348439 | PFIZER | 83.00 | YR | F | Y | 71.00000 | KG | 20160913 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125998524 | 12599852 | 1 | PS | TIKOSYN | DOFETILIDE | 1 | UNK, 2X/DAY (2.5, TWICE A DAY) | U | 20931 | CAPSULE, HARD | BID | ||||||||
| 125998524 | 12599852 | 2 | SS | TIKOSYN | DOFETILIDE | 1 | UNK, 2X/DAY (250 TWICE A DAY) | U | 20931 | CAPSULE, HARD | BID | ||||||||
| 125998524 | 12599852 | 3 | SS | ALTACE | RAMIPRIL | 1 | UNK (05) | N | 19901 | ||||||||||
| 125998524 | 12599852 | 4 | SS | ALTACE | RAMIPRIL | 1 | 5 MG, 1X/DAY | N | 19901 | 5 | MG | QD | |||||||
| 125998524 | 12599852 | 5 | SS | DILTIAZEM HCL | DILTIAZEM HYDROCHLORIDE | 1 | 120 MG, 2X/DAY | 74941 | 120 | MG | BID | ||||||||
| 125998524 | 12599852 | 6 | SS | LORAZEPAM. | LORAZEPAM | 1 | 1 MG, 1X/DAY | 74243 | 1 | MG | QD | ||||||||
| 125998524 | 12599852 | 7 | SS | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | UNK (HYDROCODONE BITARTRATE 10, PARACETAMOL 325) (1 OR 2 DAY) | 0 | |||||||||||
| 125998524 | 12599852 | 8 | C | AZELASTINE HCL | AZELASTINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 125998524 | 12599852 | 9 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | 0 | |||||||||||
| 125998524 | 12599852 | 10 | C | FENOFIBRATE. | FENOFIBRATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125998524 | 12599852 | 1 | Atrial fibrillation |
| 125998524 | 12599852 | 3 | Hypertension |
| 125998524 | 12599852 | 5 | Hypertension |
| 125998524 | 12599852 | 6 | Nerve injury |
| 125998524 | 12599852 | 7 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125998524 | 12599852 | HO |
| 125998524 | 12599852 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125998524 | 12599852 | Choking | |
| 125998524 | 12599852 | Cough | |
| 125998524 | 12599852 | Dysphonia | |
| 125998524 | 12599852 | Pharyngeal oedema | |
| 125998524 | 12599852 | Productive cough |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125998524 | 12599852 | 3 | 201607 | 0 | ||
| 125998524 | 12599852 | 4 | 201607 | 0 | ||
| 125998524 | 12599852 | 7 | 2015 | 0 | ||
| 125998524 | 12599852 | 8 | 2016 | 0 | ||
| 125998524 | 12599852 | 9 | 2016 | 0 |